You are here

endometriosis

Gynica to launch trial of cannabinoid-based endometriosis therapies

Clinical Trials Arena

Wed, 03/20/24 - 11:45 am

clinical trials

Organon finally offers a larger pharma model for women's health. But 'one company can't do it by itself'

Fierce Biotech

Thu, 03/16/23 - 09:09 pm

AbbVie puts up fight against Orilissa generics from Sandoz, Teva and others

Endpoints

Mon, 10/31/22 - 04:22 pm

Teva Pharmaceuticals

Pfizer and Myovant’s endometriosis pain drug Myfembree gets another FDA nod

Endpoints

Mon, 08/8/22 - 11:28 pm

Myovant and Pfizer’s path to securing a second nod for Myfembree gets hazy — and investors react quickly

Endpoints

Tue, 04/12/22 - 10:48 am

Organon makes another women’s health move with deal for endometriosis-focused Forendo

MedCity News

Thu, 11/11/21 - 10:58 am

Myovant Squares Off with AbbVie On Endometriosis Treatment

Motley Fool

Sun, 04/26/20 - 01:49 pm

Myovant Sciences

clinical trials

AbbVie's new endometriosis drug to cost $10K per year

Biopharma Dive

Tue, 07/24/18 - 11:27 pm

AbbVie wins FDA approval for oral treatment for endometriosis pain

Marketwatch

Tue, 07/24/18 - 10:21 am

3 Biotech Stocks With Major Potential Catalysts in July

Yahoo/Motley Fool

Wed, 06/27/18 - 09:45 am

Neurocrine Biosciences

INSYS Therapeutics

AbbVie's elagolix could put pressure on budgets, ICER estimates

Biopharma Dive

Tue, 05/8/18 - 03:46 pm

Elagolix review extended

Tue, 04/10/18 - 04:36 pm

FDA Requires More Time to Review Abbvie and Neurocrine Endometriosis Drug Elagolix

CP Wire

Tue, 04/10/18 - 09:30 am

New Study Reveals Potential for DotLab Endometriosis Saliva Test to be Used for Monitoring Disease Progression and Treatment Response

CP Wire

Fri, 03/30/18 - 09:22 am

Lumenis reports exciting study outcomes for its endometriosis treatment

CP Wire

Tue, 03/27/18 - 10:07 am

Lumenis reports exciting study outcomes for its endometriosis treatment

Tue, 03/27/18 - 10:03 am

AbbVie rolls up another big win for elagolix as the prospective blockbuster sweeps endpoints in latest PhIII

Endpoints

Wed, 02/21/18 - 09:36 am

uterine fibroids

Enteris endometriosis drug moves ahead with proof-of-concept

Biopharma Dive

Thu, 01/4/18 - 11:11 am

Enteris BioPharma

This drug may be able to treat both women’s health disorders and prostate cancer

Marketwatch

Thu, 10/12/17 - 09:31 am

prostate cancer

uterine fibroids

Enteris BioPharma launches endometriosis trial with oral peptide delivery tech

Drug Delivery Business News

Tue, 09/5/17 - 06:58 pm

Enteris BioPharma

Pages